pharma (AP Photo/Mark Lennihan)

President Joe Biden's administration says it has the authority to seize certain drug patents and license them to other manufacturers in order to lower prices — a move aimed to appeal to Americans grappling with high health-care costs.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Consumer Driven Health Care
Core and Group Health
Health Care Reform
Cost-Containment
Employee Participation
Employee-Paid
Employer-Paid